Report

The Spain Endoscopy Devices Market size is estimated at USD 0.89 billion in 2024, and is expected to reach USD 1.16 billion by 2029, growing at a CAGR of 5.13% during the forecast period (2024-2029).

Key Highlights
-The COVID-19 pandemic had a significant impact on the Spain endoscopy devices market due to the lockdown and the partial or full closure of endoscopy services due to the high influx of COVID-19 patients. For instance, the Spanish Foundation of the Digestive System (SEPD) suggested reducing the number of appointments to avoid crowding in the waiting room for endoscopy.
-The impact of the COVID-19 disease prompted limiting the reasons, with some centers only allowing urgent endoscopies. Hence, COVID-19 had a significant impact on the Spain endoscopy devices market. However, with the return of endoscopy services and a decrease in COVID-19 cases, the studied market is predicted to recover from the COVID-19 reduction during the forecast period.
-Factors such as an increase in the adoption of endoscopy for the treatment and diagnosis of chronic diseases, growing preference for minimally invasive surgeries, and technological advancements in endoscopy devices are expected to drive market growth over the forecast period. For instance, as per the International Agency for Research on Cancer (IARC) estimations, 305,357 cases of new cancer cases are likely to be diagnosed by 2025 in Spain. Hence, the high prevalence of cancer cases in Spain is expected to utilize endoscopy services, thereby driving market growth over the forecast period.
-Moreover, technological advancement and product launches are likely to positively impact market growth. For instance, in November 2021, Nexus Sisinf, a technology company specializing in e-Health solutions for hospitals, health centers, and residences, presented the 'Nexus/Diagnostics' software for the preparation of gastroenterology reports at the 43rd Congress of the Spanish Society of Digestive Endoscopy (SEED). The solution can be applied in different types of examinations such as gastroscopy, colonoscopy, ERCP (endoscopic retrograde cholangiopancreatography), bronchoscopy, abdominal ultrasound, or echocardiography. It allows it to be adapted to each clinical practice and integrated with other equipment, such as endoscopy towers, ultrasound devices, washers/disinfectors, and drying cabinets.
-Hence, the high prevalence of chronic diseases that adopt endoscopes for treatment and diagnosis and technological advancements are the major factors that are leading to the growth of the market. However, the lack of skilled technicians and infections caused by few endoscopes are hindering the market growth.


Spain Endoscopy Devices Market Trends

Endoscope Segment is Expected to Witness Rapid Growth in the Market Over the Forecast Period


- The endoscopes segment is estimated to have a significant market share during the forecast period owing to factors such as the rising adoption of minimally invasive procedures, increasing technological advancements, and the rise in research studies involving endoscopes for different disease modalities.
- For instance, in October 2022, Fujifilm Europe GmbH launched EW10-VM01 software for the Scale Eye virtual real-time scaling function designed to help endoscopists estimate the size of lesions in the colon. Scale Eye is the latest technology launched as part of the Eluexo Ultra platform, offering a complete package for endoscopists. Scale Eye is activated with the push of a button on the endoscope to help the endoscopist determine the size of the lesion within the endoscopic field of view. Hence, such technical innovations are expected to bolster the demand for endoscopes in Spain over the forecast period.
- Furthermore, in October 2021, GI Windows, Inc. sponsored a clinical study to be conducted in Barcelona, Spain, to monitor weight loss and metabolic indicators for subjects in a single-center, a single-arm trial using an endoscope that was placed in the duodenum and laparoscopically into the ileum. Hence, the utilization of endoscopes for clinical studies is expected to drive segment growth over the forecast period.
- Hence, the rise in clinical studies utilizing endoscopes and technological advancements are the major factors that are leading to the growth of the segment.


Gastroenterology Segment Anticipated to Hold a Significant Share in the Market Over the Forecast Period

The gastroenterology segment is estimated to have a significant market share during the forecast period owing to the factors such as the increasing prevalence and risk rate of gastrointestinal diseases, increasing technological advancements, and the rise in research studies utilizing endoscopy devices. For instance, according to the June 2022 update by Regional Health Management, in Spain, more than 70,000 new cancers related to the Digestive System were likely to be diagnosed in 2022, according to the latest report Cancer Figures. Specifically, the most frequent digestive tumors diagnosed in the country this year were estimated to be those of the colon and rectum (43,370), pancreas (9,252), stomach (6,913), liver (6,604), gallbladder (2,834), and esophagus (2,249). Thus, the increasing number of gastrointestinal diseases across Spain is driving the growth of the market studied.

An upper GI endoscopy or EGD (esophagogastroduodenoscopy) is a procedure to diagnose and treat problems in the upper GI (gastrointestinal) tract. The upper GI tract includes the food pipe (esophagus), stomach, and the first part of the small intestine (the duodenum). This procedure is done using a long, flexible tube called an endoscope. The adherence to endoscopy by the population is a crucial factor for market growth.

An upper GI endoscopy or EGD (esophagogastroduodenoscopy) is a procedure to diagnose and treat problems in the upper GI (gastrointestinal) tract. The upper GI tract includes the food pipe (esophagus), stomach, and the first part of the small intestine (the duodenum). This procedure is done using a long, flexible tube called an endoscope. The adherence to endoscopy by the population is a crucial factor for market growth.

For instance, in February 2021, an article published in PubMed was sponsored by the Spanish Association of Gastroenterology, the Spanish Gastrointestinal Endoscopy Society, and the Spanish Anatomical Pathology Society, which aimed to establish recommendations for performing a high-quality upper gastrointestinal endoscopy for the screening of gastric cancer precursor lesions (GCPL) in low-incidence populations, such as the Spanish population. Hence, such recommendations demonstrating the need for adherence to endoscopy procedures are likely to drive market growth.

As a result, the increase in clinical research utilizing endoscopes and technical improvements are the key reasons driving the segment's growth.

Spain Endoscopy Devices Industry Overview

The Spain endoscopy devices market is moderately competitive with several major players. Some of the strategies implemented include agreements, collaborative models, business expansion, and product development. Key players are developing and launching novel products and technologies to compete with existing products, while others are acquiring and partnering with other companies trending in the market. Some of the major players are Boston Scientific Corporation, Medtronic PLC, Johnson and Johnson, Olympus Corporation, and Cook Group Incorporated.

Additional Benefits:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support